CS
AGN

Comerica Securities’s Allergan plc AGN Stock Holding History

Comerica Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,512
Closed -$310K – 417
2017
Q3 		$310K Buy
1,512
+96
+7% +$22.3K 0.04% 320
2017
Q2 		$344K Buy
1,416
+263
+23% +$61.8K 0.05% 296
2017
Q1 		$276K Sell
1,153
-285
-20% -$66.4K 0.04% 328
2016
Q4 		$302K Sell
1,438
-1,315
-48% -$272K 0.07% 271
2016
Q3 		$634K Buy
2,753
+419
+18% +$102K 0.12% 185
2016
Q2 		$539K Sell
2,334
-428
-15% -$98.7K 0.11% 202
2016
Q1 		$740K Sell
2,762
-58
-2% -$16.6K 0.17% 151
2015
Q4 		$881K Sell
2,820
-1,122
-28% -$334K 0.22% 129
2015
Q3 		$1.07M Sell
3,942
-306
-7% -$94K 0.29% 97
2015
Q2 		$1.29M Buy
4,248
+787
+23% +$235K 0.32% 96
2015
Q1 		$1.03M Buy
3,461
+133
+4% +$37.9K 0.26% 106
2014
Q4 		$857K Sell
3,328
-216
-6% -$54K 0.26% 97
2014
Q3 		$855K Buy
+3,544
New +$793K 0.29% 94

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Comerica Securities's AGN Position: Q4 2017 in Review

Comerica Securities sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,512 shares — an estimated $310K sold.

Comerica Securities first reported a position in AGN in Q3 2014 and held it in 13 quarters. The position peaked at $1.29M in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Comerica Securities reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Comerica Securities sold 1,512 Allergan plc shares in Q4 2017, an estimated $310K.
  • Comerica Securities first reported a position in Allergan plc in Q3 2014 and held it in 13 quarters.
  • Comerica Securities's Allergan plc position peaked at $1.29M in Q2 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Comerica Securities's 13F filing for Q4 2017, filed 9 Feb 2018.